# Influence of Timing PTCy in AlloSCT

> **NCT05886335** · — · COMPLETED · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 180 (actual)

## Conditions studied

- Cyclophosphamide Toxicity
- Allogenic Haematopoetic Transplantation

## Interventions

- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT05886335
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-26
- **Primary completion:** 2024-11-30
- **Final completion:** 2025-01-31
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05886335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05886335, "Influence of Timing PTCy in AlloSCT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05886335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
